PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Theriva Biologics reveals positive VCN-01 study results

The candidate is a stroma-degrading oncolytic adenovirus for the treatment of pancreatic cancer. Theriva Biologics, a company focused on developing cancer treatme...
Continue Reading →
News

Partnership aims to boost mental health research

The University of Strathclyde, the NHS and New York University join forces to increase knowledge. A significant collaboration involving the University of Strathcl...
Continue Reading →
News

Tower Cold Chain Accelerates Growth with Two New Senior Appointments

Advanced temperature-controlled container specialist, Tower Cold Chain has continued the expansion of its global team with the appointment of a Regional Commercial M...
Continue Reading →
News

Invizius gets MHRA Approval for H-Guard research

First-in-human study to be undertaken at the Manchester University Hospitals NHS Foundation Trust. Invizius, a company concentrating on second-generation therapie...
Continue Reading →
News

Okyo reaches clinical trial agreement with Tufts

Novel therapy, OK-101, offers a potential way of relieving neuropathic corneal pain. Okyo Pharma Limited – a company focused on ophthalmology – has announced a ne...
Continue Reading →
News

First patient dosed in Immutep’s soft tissue sarcoma trial

The phase 2 study involves the company’s eftilagimod alpha therapy. Immutep – a company focused on developing novel LAG-3 immunotherapies for cancer and autoimmun...
Continue Reading →
News

TVM and Tillotts form company to take on ulcerative colitis

Mage Biologics aims to progress a novel, orally administered monoclonal antibody. TVM Capital Life Science (TVM), a company that concentrates on life sciences inv...
Continue Reading →
News

ABPI reacts to new vital vaccination report

A new HSCC document deems the UK’s vaccination position to be at risk. The Health and Social Care Select Committee has published the broad results of its inquiry ...
Continue Reading →
News

First dose completed in phase 1 cannabinoid study

OCTP aims to demonstrate the lead candidate’s safety, tolerability and pharmacokinetic profile. Oxford Cannabinoid Technologies Holdings (OCTP) has announced that...
Continue Reading →
News

AstraZeneca links up with Qureight on lung disease research

The company will utilise Qureight’s AI technology to undergo studies across a variety of complex lung diseases. Qureight, a company focused on data analytics, has...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026